| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.024 | 0.9 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.02 | 0.9 |